would buyer ci see run-rat earn power pro forma co
unchang prior view without strand overhead relat ep guidanc
would like come higher report view goal
ep track new propos rule rebat non-ev
fund flow chang pbm reiter outperform
believ prior ep ex-antm would line guidanc
earli transit busi guidanc includ mm
headwind relat earli termin contract
script cost anticip ci plan unexpectedli pull
forward exercis chang control provis pbm contract
ci receiv advanc notic decis exercis chang control
believ like ci would abl better plan reduc cost line
pace busi roll importantli manag reiter
expect mm pre-tax admin synergi well long-term target
ep mm repres real cash expens
believ meaning long-term impact underli busi view
earn power combin entiti essenti prior earn
ci guidanc contempl impact capit
deploy prior year develop compani report mm favor
develop estim worth full year weight
averag share count slightli elev due close esrx believ
compani prudent give credit favor develop
advanc howev favor pyd steadi y/i estim would worth
upsid manag indic compani bb
capit avail deploy approxim bb use de-lev
balanc sheet bb use capit expenditur remain
bb avail growth invest share repurchas compani
alreadi deploy mm capit share repurchas januari
believ share ci affect concern hh propos rule chang
rebat part given signific portion ci earn come esrx
believ concern unfound rule affect medicar part
commerci market pbm alreadi offer pos discount chang
anyth new commerci market move quickli away
rebat medicar rule would like littl impact commerci market
regardless recent call host expert note differ
point-of-servic discount rebat current form see propos
impact pbm profit standpoint accord expert propos
fundament alter econom pbm health plan mani pbm
alreadi pass major rebat health plan commerci market
pleas see page report import disclosur
posit share ci believ acquisit esrx posit compani
succeed evolv healthcar landscap stand-alon basi ci carv
strong posit market particularli aso recent result demonstr
abil deliv strong result led critic compani spend
billion acquir esrx reflect rel depress valuat compar peer
believ unwarr believ investor may give enough credit
near-term growth opportun yet outlin beyond million cost synergi
greater purchas scale esrx ci posit full-risk aso
market believ strateg valu esrx even potenti near-
term accret lie long-term posit market shift toward greater care
coordin value-bas care
bp y/i
y/i
stronger expect medic custom
realiz pre-tax cost synergi excess
integr challeng lower
expect synergi esrx deal
global health servic compani subsidiari offer medic dental
disabl life accid insur relat product servic
product servic offer employ group select
intern market offer supplement health life accid insur product
intern health care coverag servic busi government non-
government organ individu decemb acquir
script largest pharmaci benefit manag script servic includ
drug util review formulari manag diseas manag medic drug
data analysi servic medic inform manag servic oper five
segment integr medic intern market oper
corpor
expert note health plan could somewhat expos believ
impact would like minim given low earn associ medicar part
propos rule alter phase coverag part member mean member
like stay within coverag phase longer spend less time catastroph
phase definit would increas cost health plan obviou respons
health plan would like form premium increas expert believ
health plan could choos absorb cost rather pass along order
remain competit
estim part repres less ci adjust earn accord
monthli part enrol report esrx list part member
note larg major part egwp offer estim legaci
esrx part risk-liv around similarli would minim impact
lower adjust ep project reflect
unanticip strand cost associ earli transit note
adjust ep estim essenti unchang maintain price
target impli upsid current level pt impli price-to-earnings
multipl adjust ep project stock current trade
continu view guidanc conserv sever reason first ep guidanc
contempl impact capit deploy prior year develop
indic favor prior year develop provid meaning posit
earn benefit capit deploy like limit benefit
compani dedic capit de-lever balanc sheet share
repurchas could provid bigger tailwind beyond final believ ci
expect mm cost synergi could prove conserv mostli
admin-rel therefor like low hang fruit furthermor mm target
includ revenu synergi believ smaller opportun
ramp outer year
updat model reflect ci new report structur incom statement
segment level model current includ estim balanc sheet cash flow
statement plan updat compani publish complet version
 expect end februari note integr medic segment result
like underst segment like overst due express
script medicar part busi re-seg integr
medic divis remain due lack inform
time implicitli model esrx part revenu cost
segment updat model see compani report result
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom incom adjust oper share outstand fulli net incom reconcili net chang servic incom end decemb cowen
million except per-shar data
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom loss adjust incom adjust oper share outstand fulli net incom reconcili amort acquir intang realiz gain chang y/i invest cost benefit servic pre-tax incom cowen
million
compani report cowen compani
matur fair secur fair long-term account note polici acquisit tax asset asset asset exclud account deposit claim claim expens medic cost polici insur contracthold payabl accru expens account non-controlling equitycommon paid comprehens treasuri stock sharehold liabil sharehold se short-term liquid ratio current receiv claim payabl structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
invest gain incom chang asset liabil net non-oper effect premium account note polici acquisit payabl accru expens incom extinguish partnership oper net cash equip purchas invest repay debt common common foreign currenc rate chang cash cash increas decreas end decemb cowen
million
compani report cowen compani
invest gain incom chang asset liabil net non-oper effect premium account note polici acquisit payabl accru expens incom extinguish partnership oper invest sold fix matur equiti matur repay fix matur equiti sale matur purchas fix matur equiti primarili short-term equip net cash invest interest credit contracthold deposit benefit payment contracthold deposit chang short-term debt long-term proce issuanc long-term common common financ cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
integr esrx anoth potenti risk particularli compani eventu
move ci live onto esrx platform also begin march begin
transit membership pbm ingeniorx support disrupt
could impact ci note esrx tsa run
transit work move would need negoti
potenti propos hh regard futur rebat could impact ci
would expect potenti impact headlin risk vs meaning impact
remain chanc administr could propos sweep broad new
